News Norstella, Citeline merge to create $5bn pharma tech firm Citeline and Norstella have completed a merger, first announced in June, to create one of the largest players in the pharmaceutical intelligence category.
Partner Content Partner Content Prescient Announces Recent Appointments to its Senior Team Prescient hires two new senior members to Senior Team
Partner Content Partner Content Prescient Announces Recent Appointments to the Senior Adviso... Prescient hires two new senior members to Advisory Team
Partner Content Partner Content Prescient Intelligence & Insight Announces Recent Appointmen... Prescient Intelligence & Insight hires 3 senior leads
Partner Content Partner Content Prescient Intelligence & Insight announces recent appointmen... Jeanne Penn, Ben Kebble & Mladen Tomich join Prescient
News ASH: Blenrep ups survival by 42% in multiple myeloma trial GSK reveals the survival data that it reckons could return BCMA drug Blenrep to the forefront of multiple myeloma treatment.
Digital Sponsored The AI effect in pharma commercial strategy: From data to re... Discover how AI is transforming the pharma commercial strategy. Unlock real-time insights & actions from data. Click here for more.